GlaxoSmithKline to pay $90M to settle Avandia claims, Bloomberg reports GlaxoSmithKline (GSK) has agreed to pay $90M to 37 states and the District of Columbia to settle claims that the company illegally promoted its diabetes medication Avandia, according to a Bloomberg report. Reference Link
News For GSK From The Last 14 Days
Check below for free stories on GSK the last two weeks.
Ligand says partner GSK submits application for Promacta Ligand Pharmaceuticals (LGND) said its partner GlaxoSmithKline (GSK) announced today the submission of a supplemental New Drug Application to the FDA for Promacta for the treatment of cytopenias in patients with severe aplastic anaemia who have had an insufficient response to immunosuppressive therapy.